Bough Bioscience

Profile

Bough Bio is a pre-clinical stage company focused on decoding the molecular biology of senescent cells to unlock new medicine for age-related disease. Its small molecule therapeutic is designed to target senescent microglial cells in the brain, along with a companion diagnostic, for the treatment of neuropsychiatric disease. Its expanding its platform to mitigate peripheral immune senescence. It aims to bring preventative measures to the clinic to stem the tide of age-related disease.

Bough Bioscience
boughbio.com

Contact

Event details

Date: November 9 - 11, 2026

Event contact

Patricia Cosgrove
Senior International Market Consultant
U.S.A. & Europe

Participants

24 participants

  • 20/20 OptimEyes Technologies

    20/20 OptimEyes Technologies is developing OPT-101, a sustained-release glaucoma eye drop designed to reduce dosing

  • Acanthus Pharma Services Inc.

    APS Pharma™ is a Canadian innovation-focused specialty chemistry

  • AlloWide Health

    AlloWide Health is an Ontario-based biotechnology company developing innovative solutions to improve the preparatio

  • Altis Labs

    Altis Labs is the AI endpoint company accelerating clinical trials.

  • BioBackers

    Lumerate’s investor intelligence brand, tracks global life science deal flow to reveal behavioral signals that connect you with the

  • BioScript Solutions

    BioScript Solutions is a Canadian healthcare company committed to simplifying access to specialty care.

  • Bough Bioscience

    Bough Bio is a pre-clinical stage company focused on decoding the molecular biology of senescent cells to unlock ne

  • Dalriada

    Dalriada is a Canadian small molecule discovery company focusing on unlocking challenging and undruggable targets l

  • Intrepid Labs

    Drug formulation has the power to transform promising compounds into life-saving therapies, yet this step is often an afterthought d

  • JN Nova Pharma

    JN Nova Pharma is a Canadian biotechnology company developing a proprietary platform technology to add

  • Kanata Bio

    Over 30% of organ transplant patients have complications due to CMV.

  • Medicenna Therapeutics

    Medicenna Therapeutics is a clinical-stage immunotherapy company engineering next-generation cytokine therapies for

  • Pattern Pharma Inc.

    Pattern’s patented PPI-100 activates innate immunity against cancers an

  • PlantForm Corporation

    PlantForm Corporation is a biopharmaceutical company focused on the rapid development and production of specialty a

  • ProteinQure Inc.

    ProteinQure has built the best computational platform for designing peptides for extra-cellular targets.

  • Q&C Services

    Q&C Services is Canada’s largest independent full-service consultant and importer for pharmaceutical, natural h

  • QurCan Therapeutics

    QurCan Therapeutics is advancing the next wave of genetic medicines for CNS

  • Rhythm Biotherapeutics Inc.

    Rhythm Biotherapeutics develops first-in-class, heart-derived exosome therapeutics to prevent atrial fibrillation.

  • Singularity Pharma

    Singularity Pharma is a drug discovery business developing novel therapeutics for

  • Specific Biologics

    Specific Biologics is developing Dualase®, an industry-leading genome editing platform with best-in-class accurate

  • TheraVac Biologics

    TheraVac Biologics is a late-stage preclinical company developing innovative immunotherapies for neurodegenerative

  • Transpharmation

    Transpharmation is a contract research organisation led by scientists.

  • Virano Therapeutics

    Virano is a genetic immunomodulation company, developing next-generation combination products which reprogram the i

  • YYZ Pharmatech Inc.

    YYZ Pharmatech Inc. (YYZ) is a deep tech company endeavoring to profoundly progress new medicine for p